Differential Expression of Interferon-Alpha Protein Provides Clues to Tissue Specificity Across Type I Interferonopathies
Lorenzo Lodi
(1, 2)
,
Isabelle Melki
(1, 3, 4)
,
Vincent Bondet
(5)
,
Luis Seabra
(1)
,
Gillian I. Rice
(6)
,
Edwin Carter
(7)
,
Alice Lepelley
(1)
,
Maria José Martin-Niclós
(1)
,
Buthaina Al Adba
(8)
,
Brigitte Bader-Meunier
(4)
,
Magalie Barth
(9)
,
Thomas Blauwblomme
(10)
,
Christine Bodemer
(11)
,
Odile Boespflug-Tanguy
(3)
,
Russel C. Dale
(12)
,
Isabelle Desguerre
(13)
,
Camille Ducrocq
(3)
,
Fabienne Dulieu
(14)
,
Cécile Dumaine
(3)
,
Pierre Ellul
(15, 16)
,
Alice Hadchouel
(17)
,
Véronique Hentgen
(18)
,
Miguel Hié
(19)
,
Marie Hully
(13)
,
Eric Jeziorski
(20)
,
Romain Lévy
(4)
,
Fanny Mochel
(21, 22)
,
Simona Orcesi
(23, 24)
,
Sandrine Passemard
(3)
,
Marie Pouletty
(3)
,
Pierre Quartier
(4)
,
Florence Renaldo
(25)
,
Rainer Seidl
(26)
,
Jay Shetty
(27)
,
Bénédicte Neven
(4)
,
Stéphane Blanche
(4)
,
Darragh Duffy
(5)
,
Yanick J. Crow
(1, 7)
,
Marie-Louise Frémond
(1, 4)
1
Equipe Inserm U1163 -
Laboratory of neurogenetics and neuroinflammation
2 Azienda Ospedaliero Universitaria A. Meyer [Firenze, Italy]
3 AP-HP Hôpital universitaire Robert-Debré [Paris]
4 Service d'immuno-hématologie pédiatrique [CHU Necker]
5 Immunologie Translationnelle - Translational Immunology lab
6 University of Manchester [Manchester]
7 University of Edinburgh
8 Sidra Medicine [Doha, Qatar]
9 MITOVASC - MitoVasc - Physiopathologie Cardiovasculaire et Mitochondriale
10 Service de neurochirurgie pédiatrique [CHU Necker]
11 Service de dermatologie [CHU Necker]
12 The University of Sydney
13 Service de neurologie pédiatrique [CHU Necker]
14 CHU-Lenval - Hôpitaux Pédiatriques de Nice Lenval
15 Child and Adolescent Psychiatry Department [AP- HP Hôpital Robert Debré]
16 I3 - Immunologie - Immunopathologie - Immunothérapie [CHU Pitié Salpêtrière]
17 Service de Pneumologie Allergologie [CHU Necker]
18 CHV - Centre Hospitalier de Versailles André Mignot
19 Centre National de Référence du Lupus Systémique, Syndrome des Anticorps Anti-phospholipides et Maladies Auto-immunes Systémiques Rares [CHU Pitié Salpêtrière]
20 Département Pédiatrie [CHRU Montpellier]
21 UF Neurométabolique Bioclinique et Génétique [CHU Pitié-Salpêtrière]
22 ICM - Institut du Cerveau = Paris Brain Institute
23 Fondazione "Istituto Neurologico Nazionale C. Mondino"
24 UNIPV - Università degli Studi di Pavia = University of Pavia
25 CHU Trousseau [APHP]
26 Medizinische Universität Wien = Medical University of Vienna
27 Royal Hospital for Sick Children [Edinburgh]
2 Azienda Ospedaliero Universitaria A. Meyer [Firenze, Italy]
3 AP-HP Hôpital universitaire Robert-Debré [Paris]
4 Service d'immuno-hématologie pédiatrique [CHU Necker]
5 Immunologie Translationnelle - Translational Immunology lab
6 University of Manchester [Manchester]
7 University of Edinburgh
8 Sidra Medicine [Doha, Qatar]
9 MITOVASC - MitoVasc - Physiopathologie Cardiovasculaire et Mitochondriale
10 Service de neurochirurgie pédiatrique [CHU Necker]
11 Service de dermatologie [CHU Necker]
12 The University of Sydney
13 Service de neurologie pédiatrique [CHU Necker]
14 CHU-Lenval - Hôpitaux Pédiatriques de Nice Lenval
15 Child and Adolescent Psychiatry Department [AP- HP Hôpital Robert Debré]
16 I3 - Immunologie - Immunopathologie - Immunothérapie [CHU Pitié Salpêtrière]
17 Service de Pneumologie Allergologie [CHU Necker]
18 CHV - Centre Hospitalier de Versailles André Mignot
19 Centre National de Référence du Lupus Systémique, Syndrome des Anticorps Anti-phospholipides et Maladies Auto-immunes Systémiques Rares [CHU Pitié Salpêtrière]
20 Département Pédiatrie [CHRU Montpellier]
21 UF Neurométabolique Bioclinique et Génétique [CHU Pitié-Salpêtrière]
22 ICM - Institut du Cerveau = Paris Brain Institute
23 Fondazione "Istituto Neurologico Nazionale C. Mondino"
24 UNIPV - Università degli Studi di Pavia = University of Pavia
25 CHU Trousseau [APHP]
26 Medizinische Universität Wien = Medical University of Vienna
27 Royal Hospital for Sick Children [Edinburgh]
Isabelle Melki
- Function : Author
- PersonId : 766552
- ORCID : 0000-0002-8057-333X
- IdRef : 158851897
Vincent Bondet
- Function : Author
- PersonId : 746608
- IdHAL : vincent-bondet
- ORCID : 0000-0002-6534-0984
Luis Seabra
- Function : Author
- PersonId : 806099
- ORCID : 0000-0002-4678-3026
Alice Lepelley
- Function : Author
- PersonId : 762742
- ORCID : 0000-0001-8656-7291
Brigitte Bader-Meunier
- Function : Author
- PersonId : 764839
- ORCID : 0000-0001-8476-8196
- IdRef : 058551522
Cécile Dumaine
- Function : Author
- PersonId : 793898
- ORCID : 0000-0003-2041-0333
Pierre Ellul
- Function : Author
- PersonId : 801871
- ORCID : 0000-0003-1862-6952
Alice Hadchouel
- Function : Author
- PersonId : 762110
- ORCID : 0000-0001-7451-9890
Romain Lévy
- Function : Author
- PersonId : 803470
- ORCID : 0000-0002-6393-0198
Simona Orcesi
- Function : Author
- PersonId : 765375
- ORCID : 0000-0001-8947-9342
Sandrine Passemard
- Function : Author
- PersonId : 759229
- ORCID : 0000-0002-0242-4566
Pierre Quartier
- Function : Author
- PersonId : 764841
- ORCID : 0000-0002-1769-549X
- IdRef : 139645683
Darragh Duffy
- Function : Author
- PersonId : 746816
- IdHAL : darragh-duffy
- ORCID : 0000-0002-8875-2308
- IdRef : 201316919
Yanick J. Crow
Connectez-vous pour contacter l'auteur
- Function : Correspondent author
- PersonId : 11918
- IdHAL : yanick-crow
- ORCID : 0000-0001-7211-7564
- IdRef : 227205359
Connectez-vous pour contacter l'auteur
Marie-Louise Frémond
Connectez-vous pour contacter l'auteur
- Function : Correspondent author
- PersonId : 1094054
Connectez-vous pour contacter l'auteur
Abstract
Whilst upregulation of type I interferon (IFN) signaling is common across the type I interferonopathies (T1Is), central nervous system (CNS) involvement varies between these disorders, the basis of which remains unclear. We collected cerebrospinal fluid (CSF) and serum from patients with Aicardi-Goutières syndrome (AGS), STING-associated vasculopathy with onset in infancy (SAVI), presumed monogenic T1Is (pT1I), childhood systemic lupus erythematosus with neuropsychiatric features (nSLE), non-IFN-related autoinflammation (AI) and non-inflammatory hydrocephalus (as controls). We measured IFN-alpha protein using digital ELISA. Eighty-two and 63 measurements were recorded respectively in CSF and serum of 42 patients and 6 controls. In an intergroup comparison (taking one sample per individual), median CSF IFN-alpha levels were elevated in AGS, SAVI, pT1I, and nSLE compared to AI and controls, with levels highest in AGS compared to all other groups. In AGS, CSF IFN-alpha concentrations were higher than in paired serum samples. In contrast, serum IFN was consistently higher compared to CSF levels in SAVI, pT1I, and nSLE. Whilst IFN-alpha is present in the CSF and serum of all IFN-related diseases studied here, our data suggest the primary sites of IFN production in the monogenic T1I AGS and SAVI are, respectively, the CNS and the periphery. These results inform the diagnosis of, and future therapeutic approaches to, monogenic and multifactorial T1Is.